Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
141.11
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 19, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
600
Open
141.11
Bid (Size)
140.00 (100)
Ask (Size)
142.07 (100)
Prev. Close
141.11
Today's Range
141.11 - 141.11
52wk Range
93.37 - 157.29
Shares Outstanding
1,253,809,440
Dividend Yield
2.24%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Record-Breaking M&A Renaissance of 2026: Why Deal Values are Soaring as Volume Dips
March 19, 2026
As the first quarter of 2026 draws to a close, the U.S. financial landscape has been reshaped by a staggering surge in corporate consolidation. Total deal value for the quarter reached a historic...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Workforce
3 Reasons to Avoid GILD and 1 Stock to Buy Instead
March 18, 2026
Since March 2021, the S&P 500 has delivered a total return of 70.9%. But one standout stock has nearly doubled the market - over the past five years, Gilead ...
Via
StockStory
Topics
Stocks
Performance
YTD
+16.0%
+16.0%
1 Month
-9.1%
-9.1%
3 Month
+16.2%
+16.2%
6 Month
+24.2%
+24.2%
1 Year
+31.3%
+31.3%
More News
Read More
This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal
↗
March 16, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
GILEAD SCIENCES INC (NASDAQ:GILD): A Durable Dividend Stock for Income Investors
↗
March 10, 2026
Via
Chartmill
Movers and shakers in today's after-hours session for S&P500 stocks?
↗
March 16, 2026
Via
Chartmill
2 Mega-Cap Nasdaq Stocks with Unusual Options Activity: What to Watch
March 16, 2026
Via
Barchart.com
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years
↗
March 11, 2026
Via
Benzinga
2 Recession-Resistant Dividend Stocks to Buy Now
↗
March 11, 2026
Via
The Motley Fool
Topics
Economy
What 16 Analyst Ratings Have To Say About Gilead Sciences
↗
March 10, 2026
Via
Benzinga
3 Blue-Chip Stocks Built for a Rotating Market
↗
March 08, 2026
Via
MarketBeat
These 3 Cash Flow Machines Provide Stability in Uncertain Markets
↗
March 06, 2026
Via
MarketBeat
Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing
↗
March 04, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Compugen (CGEN) Q4 2025 Earnings Call Transcript
↗
March 02, 2026
Via
The Motley Fool
Topics
Earnings
Gilead Foundation Awards $12 Million to Empower Community Health Workers and Expand HIV Prevention Initiatives Across 14 States and the District of Columbia
March 02, 2026
From
Gilead Sciences, Inc.
Via
Business Wire
Arcellx President Sells $10 Million Worth of Shares After Acquisition Announcement
↗
March 02, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Arcellx President Sells $10M Worth of Shares After Acquisition Announcement
↗
March 02, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
P/E Ratio Insights for Gilead Sciences
↗
February 27, 2026
Via
Benzinga
What's going on in today's session: S&P500 movers
↗
February 27, 2026
Via
Chartmill
Uncover the latest developments among S&P500 stocks in today's session.
↗
February 27, 2026
Via
Chartmill
Gilead Sciences Stock: Is GILD Outperforming the Healthcare Sector?
February 27, 2026
Via
Barchart.com
Topics
ETFs
Kymera (KYMR) Q4 2025 Earnings Call Transcript
↗
February 26, 2026
Via
The Motley Fool
Topics
Earnings
Merck's Two-Drug HIV Regimen Challenges Industry Standards Following Positive Phase 3 Results
February 26, 2026
Via
MarketMinute
Topics
Intellectual Property
Arcus (RCUS) Q4 2025 Earnings Call Transcript
↗
February 25, 2026
Via
The Motley Fool
Topics
Earnings
Gilead’s Twice-Yearly HIV Breakthrough: A Paradigm Shift in Global Prevention and Market Dominance
February 25, 2026
Via
MarketMinute
Topics
Intellectual Property
Eli Lilly Bolsters Genetic Medicine Portfolio with $2.4 Billion Acquisition of Orna Therapeutics
February 25, 2026
Via
MarketMinute
Topics
Intellectual Property
Frequently Asked Questions
Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 141.11
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 03/19/26 04:00 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 176.93B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 177B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.